Vincent CORVEST, Senior Scientist & Business Manager at CALIXAR will give a talk during the World Vaccine Congress at Washington on 21st April.
CALIXAR is a biotech company specialized in the identification and isolation of functional membrane therapeutic targets and antigens (GPCRs, Ion channels, Transporters, …). Through its experience in the production and expression of native membrane proteins CALIXAR has developed an innovative proprietary detergent-based approach consisting either in inactivating native viruses while keeping the viral envelope intact, or in improving the solubilization and the stabilization of viral antigens without any mutation, truncation and fusion.
Vincent will be pleased to present you our approach to solubilize and stabilize the structural E3-E2-6K-E1 protein complex of the Chikungunya virus (CHIKV) during the conference related to “Emerging and Infectious Diseases”.
Meet Vincent during these 4 days of event to learn more on CALIXAR’s proprietary technology and exchange with him on the generation of new drugs, antibodies, or vaccines of challenging virus and bacteria.
To join us at this event, we are glad to offer you a 25% discount on your conference ticket by following this link: World Vaccine Congress – 25%
About World Vaccine Congress
For the past 21 years, the World Vaccine Congress of Washington has evolved and grown into the leading vaccines congress globally, with hundreds of speakers, thousands of attendees, and hundreds of networking opportunities.